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Ac2O Acetic anhydride 
Ac Acetyl 
MeCN Acetonitrile 






13C-NMR Carbon Nuclear Magnetic Resonance 







Et2O Diethyl ether 
ESI Electro Spray Ionization 
EtOH Ethanol 
Fmoc 9-fluorenylmethoxycarbonyl 






MS Mass Spectrometry 
MeOH Methanol 
NMM N-methylmorpholine 
Pd(OAc)2 Palladium acetate 
Pbf 2,2,4,6,7-pentamethyI-2,3-dihydrobenzofuran-5-sulfonyl 
PhSiH3 Phenylsilane 
1H-NMR Proton Nuclear Magnetic Resonance 
tR Retention time 
rt Room temperature 
SPPS Solid Phase Peptide Synthesis 
HBTU 2-[(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate] 
PPh3 Triphenylphosphine 
TLC Thin Layer Chromatography 
TFA Trifluoroacetic acid 
TIS Triisopropylsilane 
TNBS 2,4,6-trinitrobenzenesulfonic acid 





The aim of this project is to couple a viologen derivative to a short peptide sequence, 
from the basic region of the GCN4 transcription factor, using a solid phase Zincke 
reaction. Due to the chemical properties of viologens, the desired conjugate could form 
supramolecular complexes with cucurbit[8]uril that allow to control their dimerization 
and biological function in response to external stimuli. 
With this purpose in mind, the required activated viologen and peptide derivative were 
successfully synthesized. The coupling of the activated viologen to the orthogonally 
deprotected Lys side chain located at the C-terminus of the peptide sequence was 
carried out using a solid phase Zincke reaction. 
In order to follow all the reactions and characterize intermediates and products, NMR 
and HPLC-MS were the techniques used for this purpose. The final viologen-peptide 
conjugate was purified by semipreparative reversed-phase HPLC. 












El objetivo de este proyecto es el acoplamiento de un derivado de un viológeno a una 
secuencia corta de un péptido, derivado de la región básica del factor de transcripción 
GCN4, usando una reacción de Zincke en fase sólida. Gracias a las propiedades 
químicas de los viológenos, el conjugado deseado puede formar complejos 
supramoleculares con el cucurbit[8]uril, lo que permitiría controlar su dimerización y 
función biológica en respuesta a estímulos externos. 
Teniendo esto en mente, el viológeno activado y el derivado del péptido fueron 
sintetizados satisfactoriamente. El acoplamiento entre el viológeno activado y la 
cadena lateral desprotegida ortogonalmente de la lisina, situada en el extremo C-
terminal de la secuencia del péptido, se llevó a cabo utilizando una reacción de Zincke 
en fase sólida.  
Para seguir todas las reacciones y caracterizar los intermedios y los productos, RMN y 
HPLC-MS fueron las técnicas utilizadas para este fin. El conjugado final viológeno-
péptido fue purificado mediante HPLC semipreparativo en fase reversa. 
Palabras clave: síntesis de péptidos en fase sólida, química supramolecular, 











O obxectivo deste proxecto é o acoplamento dun derivado dun violóxeno a unha 
secuencia corta dun péptido, derivado da rexión básica do factor de transcripción 
GCN4, usando unha reacción de Zincke en fase sólida. Grazas ás propiedades 
químicas dos violóxenos, o conxugado desexado pode formar complexos 
supramoleculares co cucurbit[8]uril, o que permitiría controlar a súa dimerización e 
función biolóxica en resposta a estímulos externos. 
Tendo isto en mente, o violóxeno activado e o derivado do péptido foron sintetizados 
satisfactoriamente. O acoplamento entre o violóxeno activado e a cadea lateral 
desprotexida ortogonalmente da lisina, situada no extremo C-terminal da secuencia do 
péptido, levouse a cabo utilizando unha reacción de Zincke en fase sólida.  
Para seguir todas as reaccións e caracterizar os intermedios e os productos, RMN e 
HPLC-MS foron as técnicas utilizadas para este fin. O conxugado final violóxeno-
péptido foi purificado mediante HPLC semipreparativo en fase reversa. 
Palabras clave: síntese de péptidos en fase sólida, química supramolecular, 











Proteins and peptides: Structure and bonding 
Peptides and proteins are polymers formed by monomeric subunits that are called 
amino acids. There are 20 essential amino acids and all of them are characterized by a 
common structure: a carboxylic acid with an amino group attached to the Cα, which is 
the reason why they are called α-amino acids. For each one of the α-amino acids, the 
α-carbon is bonded to different side chains, which is key to differentiate one amino acid 
from other. The standard amino acid structure is shown in Figure 1. 
 
Figure 1. Structure of a standard amino acid 
There are two types of amino acids, D or L, the difference between them is the position 
of the amine group respect to the Cα (see Figure 2); they are stereoisomers. In 
proteins, all amino acids are L. 
 
Figure 2. D and L configurations of amino acids 
Amino acids can be classified depending on the polarity and acid/basic character of 
their side chain. In this way, we find acid amino acids (D, E), basic amino acids (K, R, 
H), polar amino acids (S, T, N, Q, Y, C) and non-polar amino acids (G, A, V, L, I, M, F, 





Table 1. Periodic chart of amino acids1 
Amino acids have at least 2 pKa values as all of them have two ionizable functional 
groups, the carboxylic acid and the amine. Some amino acids can have more than 2 
ionizable groups because of their side chains. The isoelectric point (pI) is the pH value 
in which the overall net charge is equal to zero. 
Amino acids are bonded between them by a peptide bond in order to form the primary 
structure of proteins and peptides. The bond is formed by the condensation of the 
carboxyl group of one amino acid and the amine of other, forming the corresponding 
amide bond and liberating one water molecule (Scheme 1). The amino acid coupled by 
its carboxyl group would stay at the N-terminus and the amino acid coupled by its 
amine would rest at the C-terminus in the formed peptide. 
                                                             





Scheme 1. Peptide bond formation 
The peptide bond has a certain double bond character, due to the resonance of the 
electronic pair of the N atom with the C=O double bond (as can be seen in Figure 3). 
 
Figure 3. Resonance form of the peptide bond 
Due to this resonance on the structure, the peptide bond is rigid and there is no free 
rotation (ω angle is fixed). On the other hand, the σ bonds formed between Cα-N and 





















Figure 4. Different bonds rotation 
By agreement, the structures are represented from the N-terminus to the C-terminus. 
The representation of the L-amino acids, linked by a trans peptide bond, is represented 
in Figure 52. 
 
 
Figure 5. Six-residue polypeptide segment representation2 
Polypeptide fragments of a protein can fold and adopt different secondary structures. 
The first one was proposed by Pauling and is the most observed in proteins; it is called 
the α-helix. This structure has helicoidal shape and C=O and NH groups are linked by 
H bonds parallel to the main axis; this bond is formed between the amine group of one 
residue i and the carbonyl group from another amino acid i+4 of the sequence (Figure 
6 (a)). Another common secondary structure is the β-sheet conformation, in which the 
different chains interact between them by H bonds perpendicular to the main axis of the 
polypeptide chains (Figure 6 (b)). The tertiary structure is the geometrical and spatial 
disposition (3D) of the different secondary structures within the protein sequence and 
the quaternary structure is formed by the interactions of two or more protein sequences 
                                                             







via non-covalent bonds2. These non-covalent bonds can be H bonds between amino 
acid side chains, ionic interactions between one carboxylic group and one amine of 
different amino acid side chains, hydrophobic interactions which implies the interaction 
between apolar groups of the amino acid side chains that would be in some way 
“hided” from the medium or the water in which usually are the proteins, and Van der 
Waals forces. Disulfide bridges (S-S) between Cys residues, that is, one sulfur atom of 
a Cys is bonded with another sulfur atom of another Cys of other secondary structure, 
is a type of covalent bonds that can be formed. 
 
Figure 6. (a) α-helix and (b) β-sheet conformations3 
Solid Phase Peptide Synthesis (SPPS) 
Peptides can be synthesized in solution, in solid phase or by a combination of both. 
The most common one is the Solid Phase Peptide Synthesis (SPPS) developed by 
Merrifield in 19654. This method is based on the anchoring of the first amino acid, 
located at the C-terminus of a peptide sequence, to an insoluble polymer resin and, 
after that, the following amino acids are coupled to the resin with their amine groups 
and side chains protected (if some reactive group is present), continuing the synthesis 
                                                             
3 Obtained from https://www.chemtube3d.com/images/aleximages/26-3.png (accessed on Jul 23, 2020) 




from the C-terminus to the N-terminus. For the coupling of each amino acid a 4 step 
cycle consisting on the cleavage of the amine-protecting group, washing, coupling of a 
protected amino acid and washing is repeated. The excess of reactants and soluble by-
products can be removed by filtering and washing to ensure their correct elimination. In 
order to achieve a successful synthesis is fundamental to do a good choice of the solid 
support and protecting groups. 
The main characteristic of SPPS is that the product is bonded all the time to a 
polymeric support. Therefore, the election of the polymeric resin is important because it 
has to be well solvated in the reaction solvent to allow the efficient entering of the 
reagents to the immobilized polypeptide chain within the resin. The linker that connects 
the peptide with the resin is also important because it provides a reversible connection 
between the peptide and the resin and, at the same time, protects the C-terminus while 
the peptide is synthesized. Furthermore, the linker also determines the functionality of 
the peptide C-terminus. 
To carry out effective peptide couplings avoiding side reactions with the amino acid 
side chains, those must be permanently protected during the peptide synthesis. For 
this purpose the amino acids have protecting groups that are orthogonal to the amine 
protecting group, so they are not affected during the deprotection step5. As summary of 
the peptide synthesis methodology, the Scheme 2 shows the main steps of the SPPS. 
                                                             






Scheme 2. Methodology for the SPPS 
For SPPS there are two methodologies that differentiate in the combination of 
protecting groups used for the peptide synthesis: Boc/Bn or Fmoc/tBu6. 
In Boc/Bn methodology, a Boc (tert-butoxycarbonyl) protecting group is used for the 
temporary protection of the α-amine nitrogen and Bn (benzyl) group is used to protect 
the amino acids side chains. Boc is deprotected in acid media with TFA (Figure 7 a)). 
In Fmoc/tBu methodology, an Fmoc (9-fluorenylmethoxycarbonyl) protecting group is 
used for the temporary protection of the amine and tBu (tert-butyl) is used to protect the 
amino acid side chains7. In this case, the Fmoc is easily removed in basic media with 
piperidine (Figure 7 b)). 
Amino acid side chain protecting groups are generally selective so that they are 
cleaved under the same conditions used for the release of the peptide from the resin. 
In the case of the Boc/Bn strategy, the cleavage requires strong conditions (treatment 
with HF or trifluoromethanesulfonic acid), while in the case of Fmoc/tBu strategy it is 
sufficient with TFA treatment. 
                                                             
6 Solid-Phase Peptide Synthesis, 2002363; Global Marketing, Bachem Group, 2016 
7 Fields, G. B.; Noble, R. L. Solid Phase Peptide Synthesis Utilizing 9-Fluorenylmethoxycarbonyl Amino 

























Figure 7. Strategies for the cleavage of Boc/Bn and Fmoc/tBu protecting groups7 
The Fmoc/tBu methodology was developed because of the problems that the 
continuous use of TFA could generate on the amino acid side chains. In this strategy, 
the TFA is only used in the last step of the synthesis to liberate the peptide of the resin 
and the deprotection of the Fmoc group is carried out with piperidine that is a mild 
base. In addition, the Boc/Bn strategy presents another disadvantage; the HF that must 
be used at the final deprotection step is highly dangerous7. 
As it has been mentioned before, the main step of the peptide synthesis is the 
formation of the peptide bond between amino acids and, in order to make efficient 
couplings, the carboxyl group must be activated. There are 4 different ways to carry out 
this activation: 
1- Carbodiimides: Are one of the more used activating agents. Their main 
disadvantage is that they can cause dehydration of Asn and Gln residues, that 
has to be avoided by adding HOBt to the reaction mixture. One of these 
activating agents is the N,N’-dicyclohexylcarbodiimide (DCC): 
 
2- Acid anhydrides: Mainly used for Boc synthesis, they are usually generated in 
situ using 1 eq of DCC and 2 eq of the corresponding protected amino acid. 
3- Active esters: The peptide coupling requires the use of the derivatized amino 
acids, (highly reactive esters), as for example with HOBt. 
4- In situ formation of active esters: Is the most important method because it is 
easy to use and allows to carry out clean and fast reactions without side 




degradation in presence of DIEA, which is the most used base in SPPS8. Some 
of them can be seen in Figure 8. 
 
Figure 8. Common coupling agents used in SPPS 
The mechanism of the activation reaction, in situ formation of the active ester and 
coupling with the amino acid of the peptide for the case of HBTU is presented in 
Scheme 3: 
 
Scheme 3. Acid activation, in situ formation of the active ester and coupling with the amino acid of the peptide 
The most important advantage in solid phase synthesis over the classical methodology 
in solution is that reagents can be used in excess to guarantee high yields in each step 
of the synthesis. The main limitation of this methodology is that the side products that 
could be generated on each step of the synthesis would be accumulated, and at the 
                                                             
8 Albericio, F.; Bofill, J. M.; El-Faham, A.; Kates, S. A. Use of Onium Salt-Based Coupling Reagents in 




end, the separation of the desired peptide from them will be difficult because their 
chromatographic characteristics are quite similar. 
Viologens in supramolecular chemistry 
Viologens are N,N’-disubstituted 4,4’-bipyridine derivatives commonly used as building 
blocks in supramolecular chemistry due to their interesting chemical properties (Figure 
9). 
 
Figure 9. General structure of viologens and pseudoviologens 
When both pyridines are substituted the structure is called viologen (Figure 9 a)) and 
when only one pyridine is substituted the structure is called pseudoviologen (Figure 9 
b)). 
Viologens can be easily prepared using nucleophilic aromatic substitution reactions 
with alkyl halides or by the Zincke reaction. 
The well-known Zincke reaction involves the use of a primary amine and a Zincke salt 
(2,4-dinitrophenyl-activated pyridinium salts) yielding a new pyridinium salt in which the 
amine group in incorporated in the heterocycle (Scheme 4). 
 
Scheme 4. General scheme of the Zincke reaction 
Viologens are π-deficient aromatic molecules and good electron-acceptors widely used 




one- or two-electron reductions (V2+ + e- ⇆ V+· + e- ⇆ V). Furthermore, because of the 
positive charges located over both ends of the viologens, they can be encapsulated as 
guests and form supramolecular inclusion complexes with cucurbit[n]uril 
macromolecules9. 
Cucurbit[n]urils (CB[n]) are a family of pumpking-shaped macromolecules obtained by 
the reaction between formaldehyde and n glycoluril units joined together by 2n 
methylene bridges (Scheme 5)10. Their inner hydrophobic cavity is accessible through 
two identical carbonyl portals, and are capable of forming inclusion complexes with 
neutral or cationic organic guests by means of hydrophobic forces, cation-dipole 
interactions, and optimization of host-guest packing coefficients. 
 
Scheme 5. Scheme of the reaction between formaldehyde and n glycoluril units10 
CB[8] with a cavity of 493 Å3 was first synthesized two decades ago11. It was the first 
reported molecule of the cucurbituril family capable of forming 1:2 complexes with 
appropriate guests. 
It forms Type A binary complexes with monocationic guests with bulky hydrophobic 
moieties. Type B and Type C binary complexes are formed with dicationic guests and 
differ on the nature of the aliphatic or electron-acceptor aromatic regions introduced in 
the cavity of the host. As mentioned before, due to the larger cavity of CB[8], Type D 
                                                             
9 Cortón, P.; Novo, P.; López-Sobrado, V.; García, M. D.; Peinador, C.; Pazos, E. Solid-Phase Zincke 
Reaction for the Synthesis of Peptide-4,4’-bipyridinium Conjugates. Synthesis 2020, 52 
10 Pazos, E.; Novo, P.; Peinador, C.; Kaifer, A. E.; García, M. D. Angew. Chem. Int. Ed. 2019, 58, 403 
11 Kim, J.; Jung, I.-S.; Kim, S.-Y.; Lee, E.; Kang, J.-K.; Sakamoto S.; Yamaguchi, K.; Kim, K. J. Am. Chem. Soc. 




homoternary 1:2 host-guest complexes can be formed as well, with two 
complementary, antiparallel and identical monocationic guests (Scheme 6)10.  
 
Scheme 6. Expected Type A-D CB[8]-guest complexes 
Taking into account the properties of both molecules, CB[8] as host and bipyridine-
based cations as guests, Kim et al. reported a Type C 1:1 complex between CB[8] and 
dimethyl-viologen (MV2+) in aqueous media. These complexes explained by Kim are 
supramolecular switches, they are capable of interchange from a Type C binary 
complex to a Type D homoternary complex after the application of external stimuli. 
When CB[8] is combined with viologens, it is sensible to redox changes and when 
CB[8] is combined with pseudoviologens, it is sensible to pH (Scheme 7)12. 
 
Scheme 7. Intramolecular redox and acid-base Type C-D switches 
                                                             




Therefore, considering the huge potential of viologen:CB[8] inclusion complexes for the 
development of stimuli-responsive systems, and the interest in the introduction of 
dynamic moieties into peptide sequences that allow to reversibly control their function 
by means of host-guest chemistry, the development of straightforward synthetic 






Peptides are ideal platforms for the development of biosensors, drugs, etc. due to their 
synthetic simplicity and functional and structural versatility. In this regard, peptide-
based conjugates have demonstrated their huge potential in many research areas, 
such as in the biomedical field. For these reasons, over the last years it has increased 
the interest in the development of synthetic methodologies that allow an efficient and 
straightforward functionalization of peptides. 
In this context, peptides have been extensively modified through the introduction on 
their structure of appropriately functionalized non-natural amino acids, and the 
subsequent use of a variety of highly efficient reactions, like Staudinger, Diels-Alder or 
Pd-catalyzed9 cross coupling reactions, to incorporate the desired functionalities. 
Moreover, recent advances in organic reactions, as for example C-H activation, have 
also paved the way to the selective modification of natural amino acid residues. 
However, despite these advances in peptide modification, there is a lack of 
methodologies for the non-covalent modification of peptides. In this regard, as it has 
been previously mentioned in the introduction, the incorporation of viologens in peptide 
sequences is highly interesting because those could act as stimuli-responsive guests in 
supramolecular complexes, allowing to reversibly control the functionality of peptides 
by host-guest chemistry. 
In the literature there are a few of examples that describe the modification of peptides 
with viologens. The first example was reported by the group of K. Plaxco in 2007 who 
described the conjugation of a viologen-functionalized bromide to a cysteine residue of 
a peptide sequence13 (Scheme 8). The main limitation of this methodology comes from 
the need of having a thiol group (cysteine residue) in the peptide sequence, which are 
sometimes easily oxidized to a disulfide bond. 
                                                             












Scheme 8. Reaction carried out by the group of K. Plaxco 
Three years later the group of A. Urbach developed a methodology for the conjugation 
of amine-functionalized viologens to the side chain of Glu residues by a peptide bond. 
This strategy results in viologen-peptide conjugates in which the viologen unit is 
connected to the peptide backbone by a relatively large linker coming from the alkyl 
amine connector and the Glu side chain (Scheme 9)14. 
 
Scheme 9. Viologen-peptide conjugate synthesis using Glu side chains 
                                                             
14 Reczek, J. J.; Rebolini, E.; Urbach, A. R. Solid-Phase Synthesis of Peptide-Viologen Conjugates. J. Org. 




More recently, the research groups of Prof. Carlos Peinador and Dr. Elena Pazos, from 
Universidade da Coruña, have developed a new methodology for the preparation of 
viologen-peptide conjugates consisting on the use of a solid-phase Zincke reaction. In 
this case, they have shown that this reaction can be used to modified short peptides 
with viologens and pseudoviologens, both at their N-terminus and in a Lys side chain 
located at the C-terminus of the peptides. Furthermore, they have also demonstrated 
that pseudoviologen derivatives can be coupled in a Lys side chain located at the C-
terminus of a long (28 amino acid) and highly charged peptide. Therefore, this method 
is a versatile and clean strategy that, a priori, allows the introduction of any activated 
viologen derivative in any amino group of a peptide (Scheme 10). 
 






As part of a larger project, which aims to develop 4,4’bipyridinium-peptide conjugates 
as artificial transcription factors that allow to control their dimerization and function in 
response to external stimuli, the main objective of this work is to synthesize a 
4,4’bipyridinium-peptide derivative that might respond to redox changes. 
Therefore, the specific objectives of this project are: 
- The synthesis of the N-activated viologen derivative (compound 2) starting from 
4,4’-bypiridine: 
 
- The synthesis of an alloc-protected peptide derived from the basic region of the 
GCN4 transcription factor by SPPS (Fmoc-P1(alloc)-R) with the following 
sequence: 
Fmoc-ESSDPAALKRARNTEAARRSRARKLQRK(alloc)-NH2 
- The coupling of the viologen derivative 2 to the orthogonally deprotected lysine 
side chain, located at the C-terminus, using a solid phase Zincke reaction to 
obtain the desired viologen-peptide conjugate Ac-P1(2): 
Results and discussion 
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Results and discussion 
Synthesis of the N-activated 4,4’-bipyridinium salt 2 as 
precursor for the Zincke reaction  
The N-activated 4,4’-bipyridinium salt 2, required for the coupling to the peptide through 
a Zincke reaction that follows an ANROC mechanism (Nucleophilic Addition, Ring 
Opening and Ring Closure)15, was obtained from the reaction of 1-chloro-2,4-
dinitrobenzene with 4,4’-bipyridine. The mechanism presented in Scheme 11, is 


























































Scheme 11. ANROC mechanism for the Zincke reaction15 
                                                             
15 Cheng, W. C.;Kurth, M. J. The Zincke reaction. A review. Org. Prep. Proced. Int. 2002, 34 (6), 585-608 
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Intermediate 1 was synthesized in a 74% yield by a nucleophilic aromatic substitution 
between 1-chloro-2,4-dinitrobenzene and 4,4’-bipyridine in EtOH under reflux (Scheme 
12). The desired product was precipitated with Et2O, washed with AcOEt and its 
identity was confirmed by 1H-NMR. 
 
Scheme 12. Synthesis of N-activated pyridinium salts 1 and 2 
As shown in Scheme 12, compound 2 was synthesized by methylation of compound 1 
with MeI in a mixture of MeCN and EtOH at room temperature. Compound 2 was 
synthesized in a 63% yield. 
Peptide synthesis 
The peptide sequence ESSDPAALKRARNTEAARRSRARKLQRK derived from the 
basic region of the GCN4 transcription factor, was chosen for the introduction of the 
viologen derivative 2 by a solid phase Zincke reaction. In order to incorporate the 
viologen at the C-terminus of the peptide sequence, an orthogonally-protected Lys (K) 
was introduced at this end with the aim of having the desired selectivity for the Zincke 
reaction. All amino groups of the amino acids are protected with Fmoc, which are 
removed during the peptide synthesis with piperidine (mechanism shown in Scheme 
13). The amino acids that have reactive side chains were also introduced with their 
side chains protected: Arg side chains were protected with Pbf (2,2,4,6,7-pentamethyI-
2,3-dihydrobenzofuran-5-sulfonyl); Gln and Asn with Trt (trityl); Lys (except the one 
located at the C-terminus) with Boc; Ser, Thr, Asp and Glu with tBu. Their structures 
are shown in Figure 1016. 
                                                             
16 Gregersen, S. Flourescent peptide-stabilized silver-nanoclusters, a solid-phase approach for high-
throughput ligand discovery. Ph.D. Thesis, Aalborg University, Aalborg (Denmark), 2014 




Figure 10. TFA labile protecting groups used 
As all of them are TFA labile, they are going to be removed in the same step. For the 
Lys residue located at the C-terminus, which has its side chain protected with an alloc 
group, is orthogonally deprotected using palladium catalysis (Pd(PPh3)4 generated in 
situ in the reaction media). The Lys deprotection mechanism can be seen in Scheme 
13. 




Scheme 13. Fmoc and Alloc deprotection mechanism schemes 
The peptide sequence was successfully synthesized by SPPS using standard Fmoc 
solid-phase peptide synthesis protocols consisting on: 1) addition of the activated 
Fmoc-protected amino acids 2) removal of the Fmoc protecting group and 3) repetition 
of steps 1 and 2 with all the amino acids of the peptide sequence. Every coupling was 
carried out in DMF for 30 min. 
After the synthesis of the whole peptide sequence Fmoc-
ESSDPAALKRARNTEAARRSRARKLQRK-NH2 was completed, a small aliquot of the 
peptide was cleaved from the resin and the crude was analyzed by HPLC-MS. As can 
be observed in the HPLC chromatogram shown in Figure 11, there is a main peak at 
tR=12,2 min that was identified by MS (Figure 12) as the desired peptide. 




Figure 11. HPLC chromatogram of the reaction crude in which the peak at 12,2 min corresponds to Fmoc-P1(alloc)-
R 
 
Figure 12. ESI-MS spectrum of the HPLC chromatogram peak at 12,2 min corresponding to Fmoc-P1(alloc)-R 
 
Viologen-peptide conjugation 
In order to perform the Zincke reaction over the deprotected Lys side chain, the peptide 
has to be first acetylated at the N-terminus before proceeding with the orthogonal 













Results and discussion 
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 Scheme 14. General scheme of the viologen-peptide conjugation 
- Acetylation 
 
Scheme 15. Scheme showing the deprotection and acetylation of the N-terminus 
In order to acetylate the N-terminus of the peptide, first a deprotection of the Fmoc 
protecting group has to be done. For this purpose, Fmoc-P1(alloc)-R was treated with 
20% 4-methylpiperidine in DMF for 15 min and the product of this reaction was treated 
with Ac2O in 0,195 M DIEA/DMF to obtain the acetylated peptide. After the acetylation 
step, a small aliquot of the peptide was cleaved from the resin and the crude was 
analyzed by HPLC-MS. As can be observed in Figure 13, the HPLC chromatogram of 
the reaction crude shows a main peak at tR=10,9 min that was identified by MS (Figure 
14) as Ac-P1(alloc)-R. The smallest peak at tR=10,5 min could not be identified by MS. 
 

















Figure 14. ESI-MS spectrum of the HPLC chromatogram peak at 10,9 min corresponding to Ac-P1(alloc)-R 
- Deprotection of the Lys(alloc) side chain 
 
Scheme 16. Deprotection of the Lys side chain 
The orthogonal removal of the alloc group from the Lys side chain at the C-terminus of 
Ac-P1(alloc)-R was carried out by treating the resin with a mixture of 0,3 eq of 
Pd(OAc)2, 1,5 eq of PPh3, 10 eq of NMM (N-methylmorpholine) and 10 eq of PhSiH3 
(phenylsilane) in DCM (dichloromethane) overnight. After the deprotection step, a small 
aliquot of Ac-P1-R was cleaved from the resin and the crude was analyzed by HPLC-
MS. As can be observed in Figure 15, the HPLC chromatogram of the reaction crude 
shows a main peak at tR=9,9 min that was identified by MS as Ac-P1-R. The smallest 
peak at tR=9,5 min could not be identified by MS. 




Figure 15. HPLC chromatogram of the reaction crude in which the peak at 9,9 min corresponds to Ac-P1-R 
 
Figure 16. ESI-MS spectrum of the HPLC chromatogram peak at 9,9 min corresponding to Ac-P1-R 
- Compound 2 coupling to the Lys side chain 
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The coupling of compound 2 to the Lys side chain was performed by treating the resin 
Ac-P1-R with a mixture of 2 (3 eq) and DIEA (1 eq) in DMF for 2,5 h. After the coupling 
step, Ac-P1(2)-R was cleaved from the resin and purified. 
As can be observed in Figure 17, the HPLC chromatogram of the purified peptide 
conjugate Ac-P1(2) only shows one peak at tR=9,6 min that was identified by MS as 
the desired viologen-peptide conjugate. 
 
Figure 17. HPLC purified chromatogram of Ac-P1(2) 
 



















All solvents used were synthesis grade, except for dimethylformamide (DMF), 
trifluoroacetic acid (TFA), and diisopropylethylamine (DIEA) that were peptide 
synthesis grade. Water was purified using a Milli-Q system (Millipore). 
TLC was the technique used in order to follow the reactions for pseudoviologen and 
viologen. Due to the polarity and the positive charge of these molecules, a mixture of 
H2O (150 mL), MeOH (150 mL), MeCN (600 mL) and NaCl (5 g) was used as eluent for 
the chromatography. The same mixture was used for the purification method. Products 
were identified with UV light at 254 nm and 360 nm. 
Small molecules were characterized by 1H-NMR and 13C-NMR in a Bruker Avance 300 
(300 MHz). Deuterated water (D2O) and deuterated MeCN (CD3CN) were used for the 
preparation of the samples. 
Reversed-phase HPLC-MS analyses were performed using a Thermo Scientific 
UltiMate 3000 connected to a single quadrupole mass spectrometer Thermo Scientific 
MSQ Plus and a PDA (Photo-Diode Array) detector.HPLC-MS quality solvents were 
used to prepare the eluents, A: 0,1% TFA, H2O and B: 0,1% TFA, MeCN. The column 
used for these analyses was Phenomenex Aeris 3,6 µm peptide XB-C18 100 Å; 150 x 
2,1 mm. The gradient used for reversed-phase HPLC-MS experiments was the 
following: 
Time (min) Flow (mL/min) % B 
0 0,300 5 
2 0,300 5 
25 0,300 95 
26 0,300 100 
32 0,300 100 
33 0,300 5 
40 0,300 5 
Table 2. Gradient for HPLC and HPLC-MS analysis 
Reversed-phase HPLC purification was carried out in an Agilent 1200 series and the 
column used was a Phenomenex Luna 5 µm C18 100 Å; 250 x 10 mm. 
The injections volumes were increased from 10 µL to 100 µL. The gradient was also 




from the gradient shown above for the analytical HPLC with a flow of 2,500 mL/min. 
For 100 µL injections, the gradient used was: 
Time (min) Flow (mL/min) % B 
0 2,500 15 
5 2,500 15 
45 2,500 50 
55 2,500 95 
Table 3. Final gradient for semipreparative HPLC purification 
The purified fractions were collected and lyophilized using a Teslar Cryodos -80 
instrument. 
The final viologen-peptide conjugate was characterized by HPLC-MS using a UHPLC 
Thermo Scientific Accela connected to a linear trap quadrupole mass spectrometer 
Thermo Scientific LTQ-Orbitrap Discovery and a PDA detector from the Research 
Support Facilities (SAI, Servizos de Apoio á Investigación) of the UDC. 
Synthesis 
1-(2,4-dinitrophenyl)-1’-methylbipyridinium chloride iodide synthesis 
















4,4’-bipyridine (1,9921 g, 12,8 mmol) and 1-chloro-2,4-dinitrobenzene (12,8 mmol, 
2,5964 g) were dissolved in 25 mL of EtOH, and then the mixture was refluxed for 24 h. 
The reaction was followed by TLC and quenched by cooling down to room 
temperature. The product was precipitated with 200 mL of Et2O yielding a white solid. 




concentrated to dryness to give compound 1 as a brown-yellowish solid in a 74% yield 
(3,396 g). 
1H-NMR (300 MHz, D2O) δ (ppm): 9,41 (d, J=2,5 Hz, 1 H), 9,26 (d, J=7,0 Hz, 2 H), 8,95 
(dd, J1=8,7 Hz, J2=2,5 Hz, 1 H), 8,86 (d, J=6,4 Hz, 1 H), 8,70 (d, J=7,0 Hz, 2 H), 8,28 
(d, J=8,7 Hz, 1 H), 8,05 (d, J=6,3 Hz, 2 H). 
 
Synthesis of 1-(2,4-dinitrophenyl)-1’-methylbipyridinium chloride iodide (2) 
 
Compound 1 (0,5007 g, 1,396 mmol) was dissolved in a 1:1 mixture of MeCN and 
EtOH (30 mL). Then, MeI (1,736 mL, 27,89 mmol) was added and the resulting mixture 
was stirred at room temperature, observing a light orange color immediately after the 
addition of MeI. After 24 h, the color of the solution was dark red, but after checking by 
TLC the reaction was not completed. MeI (0,868 mL, 13,9 mmol) was added again to 
the mixture and the reaction was stirred again for 24 h. After this time, the solution was 
still red and a precipitate was formed. The mixture was vacuum filtered and the 
precipitate was washed with 15 mL of MeCN. Compound 2 was isolated as a solid in a 
63% yield (0,4401 g). 
1H-NMR (300 MHz, D2O) δ (ppm): 9,46 (m, 3 H), 9,17 (d, 2 H, J=6,5 Hz), 9,00 (dd, 1 H, 
J1=2,5 Hz, J2=8,7 Hz), 8,87 (d, 2 H, J=7,0 Hz), 8,69 (d, 2 H, J=6,9 Hz), 8,35 (d, 1 H, 
J=8,7 Hz), 4,58 (s, 3 H). 
13C-NMR (300 MHz, D2O) δ (ppm): 153,3 (1 C), 149,9 (1 C), 149,3 (1 C), 146,6 (4 C), 
142,9 (1 C), 138,3 (1 C), 131,2 (1 C), 130,8 (1 C), 127,2 (2 C), 127,1 (2 C), 122,8 (1 C), 




HR-MS (ESI): m/z [M]+ calculated for C17H14N4O4: 338,1009  
found: 338,1023  
Synthesis of the GCN4 peptide derivative 
- Resin: H-Rink amide ChemMatrix resin (0,47 mmol/g) 
- Coupling agent: HBTU/HOBt 0,2 M 
- Base: DIEA/DMF 0,195 M 
- TNBS test for the protection/deprotection of the amine group: 1% TNBS/DMF + 
10% DIEA/DMF 
- Fmoc deprotecting agent: 4-methylpiperidine 
- Sequence: Glu-Ser-Ser-Asp-Pro-Ala-Ala-Leu-Lys-Arg-Ala-Arg-Asn-Thr-Glu-Ala-
Ala-Arg-Arg-Ser-Arg-Ala-Arg-Lys-Leu-Gln-Arg-Lys  
The peptide sequence Fmoc-P1(alloc)-R was assembled in a 0,05 mmol scale using a 
PS3 Automatic Peptide Synthesizer from Protein Technologies Inc. Amino acids were 
coupled to the resin in 4-fold excess using 2-[(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate] (HBTU) as activating agent. Each amino 
acid dissolved in DMF and activated with the coupling agent for 2 min before being 
added to the resin. Peptide couplings were carried out for 30 min. The temporal Fmoc 
protecting group was removed by treating the resin with a solution of 20% 4-
methylpiperidine in DMF for 10 min. 
Once the whole peptide sequence was synthesized, 3,5 mg of Fmoc-P1(alloc)-R were 
placed in an Eppendorf tube and resuspended in 200 μL of a cleavage cocktail (95% 
TFA, 2,5% H2O and 2,5% triisopropylsilane, TIS) and the mixture was shaken for 1,5 h. 
Then, the resin was filtered, the TFA filtrate was added over 1 mL of cold ether, and 
centrifuged. The precipitate was dried with N2. The solid was redissolved in MeCN:H2O 
(1:1) and the crude analyzed by reversed-phase HPLC. 
tR=12,2 min (column Phenomenex Aeris 3,6 µm peptide XB-C18 100 Å, lineal gradient 
5→95% MeCN, 0,1% TFA/H2O, 0,1% TFA). 
MS (ESI): m/z [MH]+ calculated for C133H239N55O41: 3527,9; found: 1764,7 [M + 2H]2+, 






Deprotection of the N-terminus 
 
After checking that the peptide synthesis was satisfactory, the N-terminus of the 
peptide was deprotected with 4-methylpiperidine. To do so, 0,05 mmol of Fmoc-
P1(alloc)-R were treated with a 20% 4-methlypiperidine solution in DMF for 15 minutes 
and washed with DMF (3 x 5 mL x 2 min). 
Acetylation of the N-terminus 
 
0,05 mmol of P1(alloc)-R were treated with a mixture of 0,195 M of DIEA/DMF (1,54 
mL) and Ac2O (23,6 µL) for 30 minutes. 
Then, the resin was filtered and washed with DMF (3 x 5 mL x 3 min), DCM (3 x 5 mL x 
3 min) and dried. 
3,5 mg of Ac-P1(alloc)-R were placed in an Eppendorf tube and resuspended in 200 
μL of a cleavage cocktail (95% TFA, 2,5% H2O and 2,5% TIS) and the mixture was 
shaken for 1,5 h. Then, the resin was filtered and the TFA filtrate was added over 1 mL 
of cold ether, and centrifuged. The precipitate was dried with N2. The solid was 
redissolved in MeCN:H2O (1:1) and the crude analyzed by reversed-phase HPLC. 
tR=10,9 min (column Phenomenex Aeris 3,6 µm peptide XB-C18 100 Å, lineal gradient 
5→95% MeCN, 0,1% TFA/H2O, 0,1% TFA). 
MS (ESI): m/z [MH]+ calculated for C137H242N54O44: 3347,84; found: 1674,6 [M + 2H]2+, 




Deprotection of the Lys(alloc) side chain 
 
Ac-P1(alloc)-R (0,05 mmol) was treated with a mixture of Pd(OAc)2 (1,7 mg, 0,00758 
mmol), PPh3 (9,8 mg, 0,0374 mmol), N-methylmorpholine (NMM, 27,5 μL, 0,25 mmol), 
PhSiH3 (30,8 μL, 0,25 mmol) in DCM (8 mL) overnight. The day after, the resin was 
filtered and washed with DCM (3 x 5 mL x 3 min), DMF (3 x 5 mL x 3 min), 
diethyldithiocarbamate (DEDTC, 25,9 mg in 5 mL of DMF) (3 x 5 mL x 3 min), DMF (3 x 
5 mL x 3 min) and DCM (3 x 5 mL x 3 min) and dried. 
3,5 mg of Ac-P1-R were placed in an Eppendorf tube and resuspended in 200 μL of a 
cleavage cocktail (95% TFA, 2,5% H2O and 2,5% TIS) and the mixture was shaken for 
1,5 h. Then, the resin was filtered, the TFA filtrate was added over 1 mL of cold ether, 
and centrifuged. The precipitate was dried with N2. The solid was redissolved in 
MeCN:H2O (1:1) and the crude analyzed by reversed-phase HPLC. 
tR=9,9 min (column Phenomenex Aeris 3,6 µm peptide XB-C18 100 Å, lineal gradient 
5→95% MeCN, 0,1% TFA/H2O, 0,1% TFA). 
MS (ESI): m/z [MH]+ calculated for C133H238N54O42: 3263,81; found: 1633,5 [M + 2H]2+, 











Compound 2 coupling 
 
Ac-P1-R (0,05 mmol) was resuspended in 5 mL of DMF and 182 μL of 0,195 M 
DIEA/DMF and 37,3 mg of compound 2 were added to the mixture. After 2,5 h the resin 
was washed with DMF (3 x 5 mL x 3 min) and DCM (3 x 5 mL x 3 min) and dried. 
3,5 mg of Ac-P1(2)-R were placed in an Eppendorf tube and resuspended in 200 μL of 
a cleavage cocktail (95% TFA, 2,5% H2O and 2,5% TIS) and the mixture was shaken 
for 1,5 h. Then, the resin was filtered, the TFA filtrate was added over 1 mL of cold 
ether, and centrifuged. The precipitate was dried with N2. 
 
Cleavage from the resin and deprotection of the semipermanent protecting 
groups 
Ac-P1(2)-R (0,05 mmol) were treated with 6 mL of the cleavage cocktail for 3 hours. 
Then, the resin was filtered and the TFA filtrate was added over 45 mL of ice-cold 
ether. After 10 min the mixture was centrifuged for 15 minutes, the supernatant was 
discarded and the precipitate was dried under N2. The precipitate was redissolved in 
900 µL of a 1:1 H2O:MeCN mixture and the crude was purified by reversed phase 
HPLC. The collected fractions were lyophilized yielding peptide Ac-P1(2) in a 21% 




tR=9,6 min (column Phenomenex Aeris 3,6 µm peptide XB-C18 100 Å, lineal gradient 
5→95% MeCN, 0,1% TFA/H2O, 0,1% TFA). 
MS (ESI): m/z [M]2+ calculated for C144H248N56O41: 1709,45; found: 1329,96 [M + H + 
5TFA]3+, 1292,30 [M + H + 4TFA]3+, 1253,97 [M + H + 3TFA]3+, 1216,30 [M + H + 
2TFA]3+, 1140,31 [MH]3+, 940,98 [M + 2H + 3TFA]4+, 912,23 [M + 2H + 2TFA]4+, 883,73 





The following conclusions can be claimed regarding the work carried out in this project: 
- The two viologen derivatives 1-(2,4-dinitrophenyl)-4-4’-bipyridinium chloride 
(compound 1) and 1-(2,4-dinitrophenyl)-1’-methylbipyridinium chloride 
iodide (compound 2) were successfully synthesized. 
- The desired peptide Fmoc-P1(alloc)-R was synthesized following standard 
solid phase peptide synthesis protocols. 
- After acetylation of the N-terminus of the peptide and the orthogonal 
deprotection of the Lys side chain, the coupling of compound 2 to the Lys side 
chain of Ac-P1-R by means of a solid phase Zincke reaction was carried out, 





Después de haber realizado este trabajo, se puede concluir lo siguiente: 
- Los dos derivados de los viológenos cloruro de 1-(2,4-dinitrofenil)-4-4’-
bipiridinio (compuesto 1) y cloroyoduro de 1-(2,4-dinitrofenil)-1’-
metilbipiridinio (compuesto 2) se sintetizaron satisfactoriamente. 
- El péptido deseado Fmoc-P1(alloc)-R se sintetizó siguiendo los protocolos de 
síntesis de péptidos en fase sólida. 
- Después de la acetilación del extremo N-terminal del péptido y de la 
desprotección ortogonal de la cadena lateral de la lisina, se llevó a cabo, 
mediante una reacción de Zincke en fase sólida, el acoplamiento del 
compuesto 2 a la cadena lateral de la lisina de Ac-P1-R y el péptido deseado 













Despois de ter realizado este traballo, pódese concluir o seguinte: 
- Os dous derivados dos violóxenos cloruro de 1-(2,4-dinitrofenil)-4-4’-
bipiridinio (composto 1) e cloroioduro de 1-(2,4-dinitrofenil)-1’-
metilbipiridinio (composto 2) sintetizáronse satisfactoriamente. 
- O péptido desexado Fmoc-P1(alloc)-R sintetizouse seguindo os protocolos de 
síntese de péptidos en fase sólida. 
- Despois da acetilación do extremo N-terminal do péptido e da desprotección 
ortogonal da cadea lateral da lisina, levouse a cabo, seguindo unha reacción de 
Zincke en fase sólida, o acoplamento do composto 2 á cadea lateral da lisina 


















Figure 19. 1H-NMR spectrum (300 MHz, D2O) for compound 1 
Compound 2 
 
































Figure 21. 13C-NMR spectrum (300 MHz, D2O) for compound 2 
 
Figure 22. ESI-MS spectrum where the peak with m/z=338,1023 corresponds to compound 2 
 +TOF MS: 0.783 to 0.916 min from Sample 2 (VL_02, MeOH) of 2019_08737_VL_02_esitof_pos_01.wiff
a=3.60227853192900730e-004, t0=-1.67311257965996880e+001 R; (Turbo Spray)
Max. 5619.9 counts.
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